Earning Analysis
Welcome to our in-depth analysis of Ceribell Inc(CBLL) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Ceribell Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Surprise Analysis
| - | 2025-11-04 | After Hours | -0.43 | -0.37 | +13.95 | 21.78M | 22.59M | +3.73 | +7.88 | +7.88 |
| - | 2025-08-05 | After Hours | -0.40 | -0.38 | +5.00 | 20.45M | 21.20M | +3.66 | -15.25 | -19.63 |
| - | 2025-05-08 | After Hours | -0.43 | -0.36 | +16.28 | 19.30M | 20.49M | +6.15 | -6.61 | -3.74 |
| - | 2025-02-25 | After Hours | -0.32 | -0.40 | -25.00 | 17.55M | 18.53M | +5.64 | -1.33 | -6.97 |
CBLL Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Ceribell Inc reported performance for , announced on 2025-11-04. The company achieved an EPS of -0.37, compared to analyst estimates of -0.43 by 13.95% . Revenue for the quarter reached 22.59M compared to expectations of 21.78M by 3.73% .
The stock price reacted with a 7.88% one-day change and a 7.88% five-day change following the earnings release. These movements reflect market reaction in Ceribell Inc growth trajectory and strategic initiatives.
CBLL Earnings Forecast
Looking ahead, Ceribell Inc(CBLL) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 1.53%, while EPS estimates have been Revise Downward by -3.06%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 2.26% . These revisions correlate with a 62.29% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Ceribell Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between CBLL's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
+1.53%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-3.06%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Upward
+2.26%
In Past 3 Month
Stock Price
Go Up
+62.29%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:88.19M
--
EPS Estimate-Annual FY 2025:-1.51
—
Stock Price19.15
CBLL Revenue and EPS Performance: A Historical Perspective
Ceribell Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
(2025-11-04,After Hours):
EPS: -0.37 (Actual) vs.-0.43 (Estimate) (13.95%)
Revenue: 22.59M (Actual) vs. 21.78M (Estimate) (3.73%)
Price Reaction: 7.88%(1-Day), 7.88%(5-Day)
(2025-08-05,After Hours):
EPS: -0.38 (Actual) vs.-0.40 (Estimate) (5.00%)
Revenue: 21.20M (Actual) vs. 20.45M (Estimate) (3.66%)
Price Reaction: -15.25%(1-Day), -19.63%(5-Day)
(2025-05-08,After Hours):
EPS: -0.36 (Actual) vs.-0.43 (Estimate) (16.28%)
Revenue: 20.49M (Actual) vs. 19.30M (Estimate) (6.15%)
Price Reaction: -6.61%(1-Day), -3.74%(5-Day)
Earnings Reaction
The chart below shows how CBLL performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CBLL sees a -0.00% change in stock price 10 days leading up to the earnings, and a -2.26% change 10 days following the report. On the earnings day itself, the stock moves by +0.64%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 7.88% on the day following the earnings release and then changed by 20.88% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Ceribell Inc (CBLL) Q3 2025 Earnings Call Summary
Positive
2025-11-04
Ceribell's earnings call presents a positive outlook with raised revenue guidance, strong gross margins, and strategic supply chain adjustments. Their market expansion into pediatrics and neonates, coupled with a new 510(k) clearance, enhances growth prospects. While competition and IP litigation pose risks, they haven't significantly impacted performance. The Q&A section reveals optimism about account growth and strategic partnerships, with some concerns about resource limitations and competition. Overall, the company's strategic initiatives and optimistic guidance suggest a positive stock price movement over the next two weeks.
CeriBell Inc (CBLL) Q2 2025 Earnings Call Summary
Positive
2025-08-05
The earnings call summary indicates positive developments such as improved gross margins due to supply chain diversification, effective cost management, and promising product launches. The Q&A reveals management's strategic focus on market expansion and addressing challenges, although some responses lack specificity. Overall, the company's initiatives and optimistic outlook, despite some uncertainties, suggest a positive sentiment. This, combined with the potential for margin improvements and market expansion, points to a likely positive stock price movement over the next two weeks.
CeriBell Inc (CBLL) Q4 2024 Earnings Call Summary
Positive
2025-03-04
The company reported significant revenue growth and improved gross margins, indicating strong financial performance. Despite increased operating expenses leading to a net loss, the guidance remains optimistic with continued investments in growth. The Q&A revealed some uncertainties about future guidance and FDA submissions, but the overall market strategy and expansion plans are positive. The stock price is likely to react positively over the next two weeks, especially given the record revenue growth and optimistic outlook for 2025.
CeriBell Inc (CBLL) Q4 2024 Earnings Call Summary
Positive
2025-03-03
The earnings report shows strong revenue growth and improved gross margins, suggesting positive financial performance. Despite increased operating expenses and net losses, the company maintains a solid cash position post-IPO. The Q&A indicates strategic investments in sales infrastructure and R&D, with a focus on future growth. While there are concerns about supply chain tariffs and unclear FDA submission details, the overall sentiment is optimistic, with expectations of accelerated growth post-2025. Given these factors, the stock is likely to experience a positive movement in the near term.
People Also Watch
FAQ
What were the key highlights of CBLL’s latest earnings report for ?
How did CBLL’s stock price react after the earnings release?
What are the revenue and EPS estimates for CBLL for undefined?
How does CBLL’s stock price correlate with earnings forecast revisions?
What should investors expect from CBLL’s next earnings report?